Phase II Evaluation of Paclitaxel and Carboplatin in the Treatment of Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study

PURPOSE: Platinum and taxane compounds have demonstrated activity in uterine carcinosarcoma (malignant mixed Mullerian tumor). Ifosfamide plus paclitaxel is the regimen with established superiority based on a randomized phase III trial conducted through the Gynecologic Oncology Group. However, the t...

詳細記述

保存先:
書誌詳細
主要な著者: Powell, Matthew A., Filiaci, Virginia L., Rose, Peter G., Mannel, Robert S., Hanjani, Parviz, DeGeest, Koen, Miller, Brigitte E., Susumu, Nobuyuki, Ueland, Frederick R.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Clinical Oncology 2010
主題:
Original Reports
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2881851/
https://ncbi.nlm.nih.gov/pubmed/20421537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.26.8326
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料